← All stocks

Pelthos Therapeutics Inc.

PTHS Net buying
CIK 0001919246 #4321 in the set updated 18 Sep 2026
Bought (120 mo)
$1.03M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$441.33K
$120.79K on a plan · $0.00 straight out of an exercise
Sold at will
$320.55K
5 of 21 sales
Net
+$584.47K
+$705.26K against sales at will

By person

8 insiders · 36 transactions

There is no salary here to measure against. Pelthos Therapeutics Inc.'s chief executive is paid a token, so dividing a holding by it says nothing.

Which is why this company is in neither direction of the chief executive filter on the transactions page. A stake that cannot be expressed as a multiple is not the same thing as a small one.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Davis Todd C
Director
$999.98K (2)
+$999.98K
1,575,834
$42.98M
+14,601%
Friedberg Ezra M
Director
$314.23K (10)
−$314.23K
111,042
$3.03M
+406.0%
Greenleaf Peter
Director
$37.50K (4) scheduled
−$37.50K
23,884
$651.40K
−6.3%
Pauls Matthew
Director
$37.00K (4) scheduled
−$37.00K
14,364
$391.75K
−3.4%
Francis Knuettel II
CFO, Treas & Secty
$16.00K (4)
$40.26K (1)
−$24.27K
30,841
$841.14K
−21.1%
Malamut Richard
Director
$9.82K (1)
$12.34K (2) scheduled
−$2.52K
118,987
$3.25M
+9.0%
LIGAND PHARMACEUTICALS INC entity
Director
1,500,000
$40.91M
Einhorn Andrew J.
Director
12,000
$327.28K

No percentages here. This company's share count has moved by a factor of 2.0 over the window, from 3,042,143 to 6,103,813 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
Greenleaf Peter
2 Jul 2026
Director
Sold on a plan
85
$27.27
$2.32K
Greenleaf Peter
2 Jul 2026
Director
Sold on a plan
712
$26.00
$18.51K
Pauls Matthew
2 Jul 2026
Director
Sold on a plan
94
$27.36
$2.57K
Pauls Matthew
2 Jul 2026
Director
Sold on a plan
692
$26.00
$17.99K
Friedberg Ezra M
2 Jul 2026
Director
Sold on a plan
24
$27.33
$655.81
Friedberg Ezra M
2 Jul 2026
Director
Sold on a plan
534
$26.03
$13.90K
Friedberg Ezra M
15 Jun 2026
Director
Sold on a plan
59
$27.94
$1.65K
Friedberg Ezra M
15 Jun 2026
Director
Sold on a plan
224
$27.12
$6.08K
Davis Todd C
11 Jun 2026
Director
Buy
503
$28.73
$14.45K
Davis Todd C
11 Jun 2026
Director
Buy
35,445
$27.80
$985.53K
Francis Knuettel II
22 May 2026
CFO, Treas & Secty
Sell indirect
1,500
$26.84
$40.26K
Greenleaf Peter
2 Apr 2026
Director
Sold on a plan
377
$21.36
$8.05K
Greenleaf Peter
2 Apr 2026
Director
Sold on a plan
420
$20.52
$8.62K
Pauls Matthew
2 Apr 2026
Director
Sold on a plan
371
$21.36
$7.93K
Pauls Matthew
2 Apr 2026
Director
Sold on a plan
415
$20.52
$8.51K
Friedberg Ezra M
2 Apr 2026
Director
Sold on a plan
265
$21.36
$5.66K
Friedberg Ezra M
2 Apr 2026
Director
Sold on a plan
293
$20.51
$6.01K
Malamut Richard
2 Apr 2026
Director
Sold on a plan
280
$21.36
$5.98K
Malamut Richard
2 Apr 2026
Director
Sold on a plan
310
$20.51
$6.36K
Friedberg Ezra M
25 Nov 2025
Director
Sell indirect
2,000
$28.01
$56.01K
Friedberg Ezra M
25 Nov 2025
Director
Sell indirect
1
$28.50
$28.50
Friedberg Ezra M
25 Nov 2025
Director
Sell indirect
2,000
$28.14
$56.27K
Friedberg Ezra M
25 Nov 2025
Director
Sell indirect
5,999
$28.00
$167.97K
LIGAND PHARMACEUTICALS INC
1 Jul 2025
10% owner
Exercised, kept
1,500,000
$10.00
$15.00M
Davis Todd C
1 Jul 2025
Director
Exercised, kept indirect
1,500,000
$10.00
$15.00M
Francis Knuettel II
1 Jul 2025
Chief Financial Officer
Exercised, kept indirect
10,000
$10.00
$100.00K
Friedberg Ezra M
1 Jul 2025
Director
Exercised, kept indirect
40,000
$10.00
$400.00K
Friedberg Ezra M
1 Jul 2025
Director
Exercised, kept indirect
40,000
$10.00
$400.00K
Francis Knuettel II
13 Sep 2024
CEO, Pres., CFO, Treas & Secty
Buy indirect
3,500
$0.97
$3.40K
Francis Knuettel II
12 Sep 2024
CEO, Pres., CFO, Treas & Secty
Buy indirect
1,700
$0.97
$1.65K
Malamut Richard
12 Sep 2024
Director
Buy indirect
10,400
$0.94
$9.82K
Francis Knuettel II
11 Sep 2024
CEO, Pres., CFO, Treas & Secty
Buy indirect
5,500
$0.94
$5.17K
Francis Knuettel II
10 Sep 2024
CEO, Pres., CFO, Treas & Secty
Buy indirect
6,500
$0.89
$5.79K
Friedberg Ezra M
21 Feb 2024
Director
Exercised, kept indirect
6,992
$4.80
$33.56K
Friedberg Ezra M
21 Feb 2024
Director
Exercised, kept indirect
13,649
$4.80
$65.52K
Davis Todd C
21 Feb 2024
Director
Exercised, kept
29,167
$4.80
$140.00K

What was left out

Form 4 filings counted 47
Amendments (4/A) skipped 11
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 16
Sales straight out of an exercise 0
Sales at will 5
Transactions with no price 0
Shares from compensation/vesting 3,206,057
History held since 23 Feb 2024